Secondary Insomnia Clinical Trial
Official title:
Metacognitive Therapy for Patients With a Psychiatric Disorder and Comorbid Insomnia.
The purpose of this study is to determine the effect of meta-cognitive therapy for insomnia.
This study is a randomized controlled trial with 50 patients with a psychiatric disorder and insomnia. The patients will be randomized into two groups of 25 patients. The first group receives meta-cognitive therapy, whereas the second group will be assigned to a waiting list control. ;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00784875 -
An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia
|
Phase 2 | |
| Active, not recruiting |
NCT01804036 -
Two Contrasting Interventions for Sleep Management
|
Phase 2/Phase 3 | |
| Completed |
NCT00105872 -
Behavioral Insomnia Therapy in Primary Care
|
N/A |